Evaluation of the effect of nano-based inhalation solution to relieve shortness of breath in COVID-19 patients
Phase 3
- Conditions
- sars-covid-19 - covid-19.COVID-19 DiseaseU07.1
- Registration Number
- IRCT20190226042851N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Positive PCR test
The patient is not COPD
Not having acute kidney problems
The patient does not have Acute liver failure
18 years and older
The patient does not need ventilator therapy
The patient has low respiratory capacity
The patient has covide-19
Exclusion Criteria
The patient is hospitalized for less than seven days
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The patient's respiratory capacity. Timepoint: Before reading And is monitored daily during the study. Method of measurement: Encouraging spirometry device - pulse oximeter - clinical examination.;Control of the patient's pulmonary infection. Timepoint: Clinical examinations and measurements of the patient's body temperature are performed daily before the study and during the study - the patient's CT scan is taken before the start of the study and at the end of the study. Method of measurement: Clinical examinations - mercury thermometer - CT scan.
- Secondary Outcome Measures
Name Time Method Compelet blood count. Timepoint: The first and last day of the study are monitored. Method of measurement: Blood sampling from the patient.;Alkaline Phosphatase. Timepoint: The first and last day of the study are monitored. Method of measurement: Blood sampling from the patient.;Urine analysis. Timepoint: The first and last day of the study are monitored. Method of measurement: Urine sampling of the patient.